Mitotic rate ≥1/mm² and residual tumor presence are linked to higher relapse risk in cutaneous melanoma patients post-excision. Lymphovascular invasion significantly correlates with worse relapse-free ...

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is dropping, and how biomarkers are driving personalized care. Cutaneous melanoma ...

Single-cell analysis and histopathological evaluation of tertiary lymphoid structures and association with survival in melanoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Adjuvant therapy improves neither melanoma-specific nor overall survival in patients with stage III disease, conclude Swedish researchers in an updated population-based study.

Staging means finding out how far melanoma has spread in the body. Providers group melanoma into stages I (1) through IV (4), with stage I melanoma being the least advanced and stage IV melanoma being ...